| Serial Number | 90160128 |
| Word Mark | EUGAMM |
| Filing Date | Friday, September 4, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 20, 2021 |
| Goods and Services | Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin preparations, namely, pharmaceutical immunoglobulin preparations for diagnosis of primary humoral immunodeficiency, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome, severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), for preventing primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), and for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP) |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 9, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Green Cross Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do 16924 KR |
| Party Name | Green Cross Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Yongin-si, Gyeonggi-do 16924 KR |
| Event Date | Event Description |
| Tuesday, September 8, 2020 | NEW APPLICATION ENTERED |
| Friday, October 9, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 12, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, January 13, 2021 | PRIORITY ACTION WRITTEN |
| Wednesday, January 13, 2021 | PRIORITY ACTION E-MAILED |
| Wednesday, January 13, 2021 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, March 10, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 11, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 10, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 31, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 20, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 20, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, May 4, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, June 15, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, November 24, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 24, 2021 | SOU EXTENSION 1 FILED |
| Wednesday, November 24, 2021 | SOU EXTENSION 1 GRANTED |
| Friday, November 26, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 4, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 4, 2022 | SOU EXTENSION 2 FILED |
| Tuesday, November 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 6, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, November 13, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, November 15, 2022 | SOU EXTENSION 3 FILED |
| Tuesday, November 15, 2022 | SOU EXTENSION 3 GRANTED |
| Thursday, November 17, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 17, 2023 | SOU EXTENSION 4 FILED |
| Wednesday, May 17, 2023 | SOU EXTENSION 4 GRANTED |
| Friday, May 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, November 6, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, November 6, 2023 | SOU EXTENSION 5 FILED |
| Monday, July 22, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, July 22, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, November 13, 2023 | SOU EXTENSION 5 GRANTED |
| Tuesday, November 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |